Improved synthesis of ADAM10 inhibitor GI254023X

Neurodegenerative Diseases

Volumn 7, Issue 4, 2010, Pages 232-238

  Hoettecke, Nicole ^a   Ludwig, Andreas ^b   Foro, Sabine ^a   Schmidt, Boris ^a  

^a DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

ADAM10; ADAM17; Cancer; Inflammation; Metalloproteinase; Neurodegenerative disease

Indexed keywords

BSC 4075; GI 254023X; METALLOPROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; PRIORITY JOURNAL; REPRODUCIBILITY;

ADAM PROTEINS; AMIDES; AMYLOID PRECURSOR PROTEIN SECRETASES; ANTINEOPLASTIC AGENTS; CELL LINE; DIPEPTIDES; HUMANS; HYDROXAMIC ACIDS; INFLAMMATION; INFLAMMATION MEDIATORS; MEMBRANE PROTEINS; NEOPLASMS; PROTEASE INHIBITORS; REPRODUCIBILITY OF RESULTS;

EID: 77953807520     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000267865     Document Type: Article

References (15)

1. Pruessmeyer J, Ludwig A: The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer. Semin Cell Dev Biol 2009; 20: 164-174.
2. Marimastat: BB 2516, TA 2516. Drugs R D 2003; 4: 198-203.
3. Groves MD, Puduvalli VK, Conrad CA, Gilbert MR, Yung WK, Jaeckle K, Liu V, Hess KR, Aldape KD, Levin VA: Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: a relationship among efficacy, joint toxicity and anticonvulsant status. J Neurooncol 2006; 80: 83-90.
4. Parsons SL, Watson SA, Steele RJ: Phase I/II trial of batimastat, a matrix metalloproteinase inhibitor, in patients with malignant ascites. Eur J Surg Oncol 1997; 23: 526-531.
5. Hundhausen C, Misztela D, Berkhout TA, Broadway N, Saftig P, Reiss K, Hartmann D, Fahrenholz F, Postina R, Matthews V, Kallen K-J, Rose-John S, Ludwig A: The disintegrinlike metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cellcell adhesion. Blood 2003; 102: 1186-1195.
6. Ludwig A, Hundhausen C, Lambert MH, Broadway N, Andrews RC, Bickett DM, Leesnitzer MA, Becherer JD: Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules. Comb Chem High Throughput Screen 2005; 8: 161-171.
7. Endres K, Postina R, Schroeder A, Mueller U, Fahrenholz F: Shedding of the amyloid precursor protein-like protein APLP2 by disintegrin metalloproteinases. FEBS J 2005; 272: 5808-5820.
8. Andrews RC, Andersen MW, Cowan DJ, Deaton DN, Dickerson SH, Drewry DH, Gaul MD, Luzzio MJ, Marron BE, Rabinowitz MH: Preparation of peptidyl formamide compounds as therapeutic agents. WO 2000012083, Research Triangle Park Glaxo Group Ltd., 2000.
9. Walz AJ, Miller MJ: Synthesis and biological activity of hydroxamic acid-derived vasopeptidase inhibitor analogues. Org Lett 2002; 4: 2047-2050.
10. Malon P, Pancoska P, Budesinsky M, Hlavacek J, Pospisek J, Blaha K: Amino acids and peptides. CLXXXII. Chiroptical properties and conformation of N -acetyl- L -amino acids N α-methylamides with aliphatic side chains. Collect Czech Chem Commun 1983; 48: 2844-2861.
11. Randolph JT, Chen H-J, Degoey DA, Flentge CA, Flosi WJ, Grampovnik DJ, Huang PP, Hutchinson DK, Kempf DJ, Klein LL, Yeung MC: Preparation of amino acid hydrazide derivatives as HIV protease inhibitors. WO 2005061487 Abbott Park, Abbott Laboratories, 2005.
12. ten Haken P, Naisby TW, Gary ACG: Fungicides of certain N -acyl amino acid derivatives and their use. The Hague, Shell Internationale Research Maatschappij B.V., 1982.
13. Katritzky AR, Chang HX, Yang B: N -Formylbenzotriazole: a stable and convenient N - and O -formylating agent. Synthesis 1995; 5: 503-505.
14. Liu M-H, Chen C, Liu C-W: Theoretical study of formamide tautomers: a discussion of enol-keto isomerizations and their corresponding energies. Struct Chem 2004; 15: 309-316.
15. Siddall TH 3rd: Direct measurement of the rate of internal rotation in a formamide. Inorg Nucl Chem Lett 1965; 1: 155-159.